MVP

0.00%

45.0¢ medical developments international limited

Does anyone know how much they cost?

First 8 Last

Share
Profile

Follow
BD3099

1,076 Posts.

79

26/07/24

14:10

Post #: 74933019
Share

Originally posted by gragou02: ↑

The chairman and ceo need to be held account at the next AGM. correct me if I'm wrong but is the value of the company is down about 90% since this ceo has been in charge?Yeah, you may be just about right with respect to price drop since the new team took over. But I'm not convinced that they're totally to blame. That share price lived above $10 for a period in early 2020 just before Covid was recognised.
It was buoyed by the undoubted success of the green whistle which proved, over many examples, just how effective it was for people in pain. Not only that but it was a pain killer that was a non-opioid which was an extremely acceptable story to present to the world.

As time has gone by, the new team has had to dismantle many of the aspirations that drove the initial excitement, They've had to change their approach to the relatively anemic marketing attempts to generate sales across several of the world's areas.
Nothing has really worked so far and nothing was included in this Capital raise request to suggest otherwise. They talked about cost efficiencies and margin improvement, which are normally healthy signs for shareholders, but what was missing was any serious attempt to talk about revenue growth and this is what is needed here at this stage.

From what I've read, "hospital" reports confirm that the green whistle is effective and quick to take effect but it's considered to be very expensive.
And, my guess is that therein lies the problem.
You can have a great product but, sometimes, they're not commercially viable on a large scale.

Maybe it is managements poor performance but maybe it's the business model. Selling an expensive solution into hospitals around the world when hospitals around the world are struggling with budget cuts, demanded by Governments floundering in debt, may be at the heart of the problem.

Expand

Does anyone know how much they cost?

MVP Price at posting: 48.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

There are more pages in this discussion • 13 more messages in this thread...

First 8 Last

Add MVP (ASX) to my watchlist

(20min delay)
Last 45.0¢		Change 0.000(0.00%)		Mkt cap ! $50.69M

Open	High	Low	Value	Volume
44.0¢	46.0¢	44.0¢	$10.2K	22.82K

Buyers (Bids)

No.	Vol.	Price($)
1	41949	45.0¢

Sellers (Offers)

Price($)	Vol.	No.
46.0¢	13548	3

View Market Depth

No.	Vol.	Price($)
1	41949	0.450
4	60439	0.440
3	36783	0.430
1	1200	0.425
1	1200	0.420

Price($)	Vol.	No.
0.460	13548	3
0.465	1193	1
0.470	2129	1
0.480	47250	3
0.485	7000	1

Last trade - 15.47pm 04/10/2024 (20 minute delay)

MVP (ASX) Chart

Does anyone know how much they cost?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Does anyone know how much they cost?

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News